Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case report

The study objective is to report a case of successful treatment of disseminated nasopharyngeal carcinoma with nivolumab.Materials and methods. A 22-year-old male patient was admitted to N.N. Blokhin National Medical Research Center of Oncology with a diagnosis of T3N3M1 stage IV nasopharyngeal carci...

Full description

Bibliographic Details
Main Authors: Yu. M. Bychkov, A. M. Mudunov, I. M. Gelfand, B. G. Pkheshkhova, O. D. Ryzhova, А. A. Akhundov, V. Z. Dobrokhotova, М. N. Narimanov
Format: Article
Language:Russian
Published: ABV-press 2019-07-01
Series:Опухоли головы и шеи
Subjects:
Online Access:https://ogsh.abvpress.ru/jour/article/view/411
_version_ 1797876166523092992
author Yu. M. Bychkov
A. M. Mudunov
I. M. Gelfand
B. G. Pkheshkhova
O. D. Ryzhova
А. A. Akhundov
V. Z. Dobrokhotova
М. N. Narimanov
author_facet Yu. M. Bychkov
A. M. Mudunov
I. M. Gelfand
B. G. Pkheshkhova
O. D. Ryzhova
А. A. Akhundov
V. Z. Dobrokhotova
М. N. Narimanov
author_sort Yu. M. Bychkov
collection DOAJ
description The study objective is to report a case of successful treatment of disseminated nasopharyngeal carcinoma with nivolumab.Materials and methods. A 22-year-old male patient was admitted to N.N. Blokhin National Medical Research Center of Oncology with a diagnosis of T3N3M1 stage IV nasopharyngeal carcinoma with bone metastasis. After a course of radical chemoradiotherapy, the patient was found to have cancer progression. Between September 2016 and July 2017, the patient received chemotherapy with 3 lines of drugs, but with no effect. We decided to initiate treatment with PD-1 inhibitors. The patient received nivolumab 3 mg/kg every 2 weeks between July 2017 and March 2018.Results. Positron emission tomography (September 2018) demonstrated no increased uptake of [18F]-fluorodeoxyglucose in earlier identified cancer foci. Since September 2018, the patient has been in persistent remission without any therapy.Conclusion. This case report demonstrates high efficacy of PD-1 inhibitors in the treatment of disseminated recurrent nasopharyngeal squamous cell carcinoma, resistant to standard radiotherapy and chemotherapy.
first_indexed 2024-04-10T01:58:53Z
format Article
id doaj.art-a55d5e928eac49639e0e281da4fc0868
institution Directory Open Access Journal
issn 2222-1468
2411-4634
language Russian
last_indexed 2024-04-10T01:58:53Z
publishDate 2019-07-01
publisher ABV-press
record_format Article
series Опухоли головы и шеи
spelling doaj.art-a55d5e928eac49639e0e281da4fc08682023-03-13T08:43:21ZrusABV-pressОпухоли головы и шеи2222-14682411-46342019-07-01929910410.17650/2222-1468-2019-9-2-99-104353Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case reportYu. M. Bychkov0A. M. Mudunov1I. M. Gelfand2B. G. Pkheshkhova3O. D. Ryzhova4А. A. Akhundov5V. Z. Dobrokhotova6М. N. Narimanov7ФГБУ «Российский научный центр рентгенорадиологии» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава РоссииФГАОУ ВО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава РоссииThe study objective is to report a case of successful treatment of disseminated nasopharyngeal carcinoma with nivolumab.Materials and methods. A 22-year-old male patient was admitted to N.N. Blokhin National Medical Research Center of Oncology with a diagnosis of T3N3M1 stage IV nasopharyngeal carcinoma with bone metastasis. After a course of radical chemoradiotherapy, the patient was found to have cancer progression. Between September 2016 and July 2017, the patient received chemotherapy with 3 lines of drugs, but with no effect. We decided to initiate treatment with PD-1 inhibitors. The patient received nivolumab 3 mg/kg every 2 weeks between July 2017 and March 2018.Results. Positron emission tomography (September 2018) demonstrated no increased uptake of [18F]-fluorodeoxyglucose in earlier identified cancer foci. Since September 2018, the patient has been in persistent remission without any therapy.Conclusion. This case report demonstrates high efficacy of PD-1 inhibitors in the treatment of disseminated recurrent nasopharyngeal squamous cell carcinoma, resistant to standard radiotherapy and chemotherapy.https://ogsh.abvpress.ru/jour/article/view/411рак носоглоткиметастазыхимиотерапияниволумаб
spellingShingle Yu. M. Bychkov
A. M. Mudunov
I. M. Gelfand
B. G. Pkheshkhova
O. D. Ryzhova
А. A. Akhundov
V. Z. Dobrokhotova
М. N. Narimanov
Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case report
Опухоли головы и шеи
рак носоглотки
метастазы
химиотерапия
ниволумаб
title Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case report
title_full Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case report
title_fullStr Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case report
title_full_unstemmed Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case report
title_short Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case report
title_sort successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab a case report
topic рак носоглотки
метастазы
химиотерапия
ниволумаб
url https://ogsh.abvpress.ru/jour/article/view/411
work_keys_str_mv AT yumbychkov successfultreatmentofrecurrentmetastaticnasopharyngealcarcinomawithnivolumabacasereport
AT ammudunov successfultreatmentofrecurrentmetastaticnasopharyngealcarcinomawithnivolumabacasereport
AT imgelfand successfultreatmentofrecurrentmetastaticnasopharyngealcarcinomawithnivolumabacasereport
AT bgpkheshkhova successfultreatmentofrecurrentmetastaticnasopharyngealcarcinomawithnivolumabacasereport
AT odryzhova successfultreatmentofrecurrentmetastaticnasopharyngealcarcinomawithnivolumabacasereport
AT aaakhundov successfultreatmentofrecurrentmetastaticnasopharyngealcarcinomawithnivolumabacasereport
AT vzdobrokhotova successfultreatmentofrecurrentmetastaticnasopharyngealcarcinomawithnivolumabacasereport
AT mnnarimanov successfultreatmentofrecurrentmetastaticnasopharyngealcarcinomawithnivolumabacasereport